Mildronate 250mg 40

MILDRONAT® (Meldonium, THP, MET-88, Mildronats, Quaterine) is an anti-ischemic drug developed for treatment of heart ischemia and its consequences. Mildronate is used in neurology for the treatment of brain circulation disorders. It significantly improves patients' mood. They become more active, their motor dysfunction decreases, and asthenia, dizziness and nausea become less pronounced. The drug also improves the learning abilities and memory.

The active substance of the drug is meldonium. The action of the drug is to prevent accumulation of cytotoxic intermediate products of fatty acid beta-oxidation in ischemic tissues and to block this highly oxygen-consuming process. Mildronate has a beneficial effect on cerebral circulation disorders and central nervous system functions. Mildronate is prescribed for patients with decreased working efficiency.

Indications for use:

• improves oxygen delivery to cells,
• excellent for sportsmen to improve stamina,
• protects cells from intoxication,
• improves energy levels and faster physical recovery,
• treat chronic heart failure and cerebral strokes,
• abstinence syndrome.

Main components:

Active substance: meldonium posphate 250mg

Recommendation for application:

Mildronate comes in capsules.
As part of combined therapy: 500-1000 mg once a day (or divide the daily dose for 2 times a day). Period of therapy is 4-6 weeks.
Chronic disorders of cerebral circulation: 500 mg once a day. Period of therapy is 4-6 weeks.
Intellectual and physical stress: 250 mg four times a day. Period of therapy is 10-14 days.
Sportsmen: 500-1000 mg two times a day before training. Duration of treatment during preparatory period is 2-3 weeks, during the period of competition 10-14 days.
Chronic alcoholism: 500 mg four times a day. Period of therapy is 7-10 days.

Form of production:

250 mg/cap, 40 caps

Guaranteed authenticity and quality:

100% Original from  GRINDEX (Latvia. EU)

Development and production:

GRINDEX (Latvia. EU)